Supporting and Maintaining a Surveillance System for Chronic Kidney Disease (CKD) in the United States

This program will build upon previous work to continue developing, supporting and enhancing the Chronic Kidney Disease (CKD) Surveillance System in the United States, to monitor the burden and trends of CKD and its risk factors over time, and monitor

This program will build upon previous work to continue developing, supporting and enhancing the Chronic Kidney Disease (CKD) Surveillance System in the United States, to monitor the burden and trends of CKD and its risk factors over time, and monitor and evaluate trends in achieving Healthy People 2030 objectives.

• Public nonprofit organizations • Private nonprofit organizations • For profit organizations • Small, minority, and women-owned businesses • Universities • Colleges • Research institutions • Hospitals • Community-based organizations • Faith-based organizations • Indian/Native American Tribal Governments (Federally Recognized) • Indian/Native American Tribal Governments (other than Federally recognized) • Indian/Native American Tribally Designated Organizations State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau). Note: A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application.

The general public will benefit from the objectives of this program. Kidney diseases are the ninth leading cause of death in the United States and more than 1 of 10 US adults may have Chronic Kidney Disease (CKD). The CKD Surveillance System is intended to raise awareness about CKD and its risk factors, promote early diagnosis, and improve outcomes for those living with CKD.

Applicants must adhere to all Centers for Disease Control and Prevention (CDC) guidelines regarding allowable and unallowable expenses. Maintain and enhance a viable and functional Chronic Kidney Disease (CKD) Surveillance System website - www.cdc.gov/ckd/surveillance. Increase the visibility of the CKD Surveillance System and disseminate the CKD surveillance findings by the number of publications and related citations in peer-reviewed journals and presentations at national and international meetings and conferences. Improve the breadth and scope of CKD surveillance data in the United States by the number of established and current data sharing and access agreements with appropriate federal, public and private partners for access to data relevant to CKD surveillance. Expand and grow the CKD Surveillance System by the number of CKD topics and indicators focusing on CKD burden and health consequences, risk factors, at-risk or vulnerable populations, and geographic indicators with up-to-date data and trends. Assess and evaluate the CKD Surveillance System content, data sources to keep or include, gaps in surveillance data, and future data and research needs. Provide data analysis reports for Healthy People 2030 progress review in achieving CKD objectives.

Restrictions, which must be taken into account while writing the budget, are as follows: •Recipients may not use funds for research. •Recipients may not use funds for clinical care. •Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual. •Awardees may not generally use U.S. Department of Health and Human Services (HHS)/ Centers for Disease Control and Prevention (CDC)/ Agency for Toxic Substances and Disease Registry (ATSDR) funding for the purchase of furniture or equipment. Any such proposed spending must be identified in the budget. •The direct and primary recipient in a cooperative agreement program must perform a substantial role in carrying out project objectives and not merely serve as a conduit for an award to another party or provider who is ineligible. •Reimbursement of pre-award costs is not allowed.

Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient.

Eligible applicants must be able to demonstrate: -Previous experience with the development of large-scale Chronic Kidney Disease (CKD) surveillance systems -Established and current data sharing and access agreements with appropriate federal, public and private partners for access to data relevant to the CKD surveillance system -A proven track record of publications related to the establishment of a national CKD surveillance system and dissemination of surveillance findings. -Previous experience with national, regional, and hospital based data pertaining to CKD and its risk factors -Previous experience with working in a collaborative multi-center project for the development and maintenance of a national surveillance system.

After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial awards provide funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, award requirements, and special conditions, if any.

Check Grants.gov for any relevant NOFO information regarding processes for applying for assistance.

Eligible applicants must be able to demonstrate: -Previous experience with the development of large-scale Chronic Kidney Disease (CKD) surveillance systems -Established and current data sharing and access agreements with appropriate federal, public and private partners for access to data relevant to the CKD surveillance system -A proven track record of publications related to the establishment of a national CKD surveillance system and dissemination of surveillance findings. -Previous experience with national, regional, and hospital based data pertaining to CKD and its risk factors -Previous experience with working in a collaborative multi-center project for the development and maintenance of a national surveillance system.

Cooperative agreement period of performance is 1 to 5 years. After initial awards, and subject to availability of funds, projects may be continued non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government.